Clinical Trial Update: SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating reduction of immunosuppression plus interferon alfa and chemotherapy for post-transplant malignant tumors; the study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Interferon Alfa (interferon alfa)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED